Aviva PLC’s Eli Lilly & Co Position
Does Aviva PLC own Eli Lilly & Co (LLY)? Yes — 712.6K shares worth $655M (+1.10% of its 13F portfolio) as of Q1 2026, up from 694.3K shares the prior filed quarter.
Position Value
$655M
Q1 2026
Shares
712.6K
% of Portfolio
+1.10%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 712.6K | $655M | +1.10% |
| Q4 2025 | 694.3K | $746M | +1.26% |
| Q3 2025 | 683.0K | $521M | +0.95% |
| Q2 2025 | 622.2K | $485M | +1.00% |
| Q1 2025 | 572.9K | $473M | +1.14% |
| Q4 2024 | 494.1K | $381M | +0.99% |
| Q3 2024 | 513.0K | $455M | +1.18% |
| Q2 2024 | 499.1K | $452M | +1.25% |
| Q1 2024 | 407.5K | $317M | +1.04% |
| Q4 2023 | 393.7K | $230M | +0.82% |
| Q3 2023 | 379.0K | $204M | +0.86% |
| Q2 2023 | 384.9K | $181M | +0.74% |
| Q1 2023 | 234.1K | $80M | +0.36% |
| Q4 2022 | 292.3K | $107M | +0.53% |
| Q3 2022 | 243.7K | $79M | +0.45% |
| Q2 2022 | 240.1K | $78M | +0.41% |
| Q1 2022 | 230.5K | $66M | +0.33% |
| Q4 2021 | 277.6K | $77M | +0.32% |
| Q3 2021 | 279.0K | $64M | +0.29% |
| Q2 2021 | 290.2K | $67M | +0.29% |
| Q1 2021 | 297.8K | $56M | +0.27% |
| Q4 2020 | 283.2K | $48M | +0.25% |
| Q3 2020 | 296.5K | $44M | +0.26% |
| Q2 2020 | 308.1K | $51M | +0.32% |
| Q1 2020 | 316.5K | $44M | +0.32% |
| Q4 2019 | 313.1K | $41M | +0.25% |
| Q3 2019 | 326.9K | $37M | +0.25% |
| Q2 2019 | 319.8K | $35M | +0.24% |
| Q1 2019 | 334.1K | $43M | +0.29% |
| Q4 2018 | 356.3K | $41M | +0.31% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aviva PLC’s full portfolio or all institutional holders of LLY.